Not checked for notices yet.
Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trials
Marit de Jong, H. Bart van der Worp, Yolanda van der Graaf and 2 more (opens in a new tab)
Cardiovascular Diabetology · 2017
doi:10.1186/s12933-017-0617-4 (opens in a new tab)
Cited by papers we hold 1
Questions about this paper
We email you if it is retracted, withdrawn, corrected or flagged.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.